Turnstone Biologics Corp. Common Stock (TSBX) Stock
TSBX is no longer traded. Turnstone Biologics Corp. Common Stock was delisted from the Nasdaq in August 2025.
Prices on this page are historical; the last trade was August 8, 2025 at $0.35.
Turnstone Biologics Corp. Common Stock stock price history
TSBX final trading statistics
- Final close
- $0.35
- Final trading day
- Aug 8, 2025
- Market cap at delisting
- $8.21M
- Shares outstanding
- 23.14M
- Final 52-week range
- $0.29 – $2.42
- Avg. volume (final 3 mo.)
- 401,156
- All-time high (split-adj.)
- $12.95 · Jul 2023
- All-time low (split-adj.)
- $0.31 · Apr 2025
- Return since IPO
- -97.0%
- Beta
- 1.37
- Book value / share
- $0.64
- Price / book
- 0.56
Turnstone Biologics Corp. Common Stock annual financials
| Fiscal year | Revenue | Net income | EPS |
|---|---|---|---|
| FY2024 | $0.00 | -$70.8M | -$3.07 |
| FY2023 | $19.31M | -$55.2M | -$9.29 |
| FY2022 | $73.30M | -$30.8M | — |
| FY2021 | $101.29M | $33.3M | — |
Last five fiscal years reported before the delisting; fiscal year ending December. EPS is adjusted (non-GAAP) EPS as reported. Source: company filings via EODHD.
About Turnstone Biologics Corp. Common Stock
Turnstone Biologics Corp. operates as a biotechnology company. The company was founded in 2014 and is headquartered in San Diego, California. As of August 11, 2025, Turnstone Biologics Corp. operates as a subsidiary of XOMA Royalty Corporation.
Turnstone Biologics Corp. Common Stock stock FAQ
What happened to Turnstone Biologics Corp. Common Stock stock?
Turnstone Biologics Corp. Common Stock stock was delisted from the Nasdaq. Its final close was $0.35 on August 8, 2025.
Is TSBX stock still trading?
No. TSBX was delisted from the Nasdaq in August 2025 and no longer trades on a U.S. exchange.
What was the last price of TSBX stock?
TSBX closed at $0.35 on its final trading day, August 8, 2025, for a market value of about $8.21M.
What were Turnstone Biologics Corp. Common Stock's revenue and earnings in its last full fiscal year?
Turnstone Biologics Corp. Common Stock reported revenue of $0.00 and net income of -$70.8M in fiscal 2024, its last full year as a public company.
When did Turnstone Biologics Corp. Common Stock go public?
Turnstone Biologics Corp. Common Stock stock began trading on July 21, 2023.